Product correctly added to cart.

discount label
N-(2-Cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoropropanamide
View 3D

Biosynth logo

N-(2-Cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoropropanamide

CAS: 1474034-05-3

Ref. 3D-FC101357

1mgTo inquire
2mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
Estimated delivery in United States, on Thursday 27 Jun 2024

Product Information

Name:
N-(2-Cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoropropanamide
Synonyms:
  • OmaveloxoloneRTA-408
Description:

N-(2-Cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoropropanamide is a creatine kinase inhibitor that can be used for the treatment of myocardial infarct, as well as for other diseases such as nephrology and dialysis. It has been shown to inhibit viral replication by preventing the mitochondrial membrane potential from being disrupted. N-(2-Cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2 difluoropropanamide also inhibits granule neurons in the brain. This drug may be a potential drug target for the treatment of Alzheimer's disease and glomerular filtration rate.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
554.71 g/mol
Formula:
C33H44F2N2O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FC101357 N-(2-Cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoropropanamide

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".